Orchestra BioMed Holdings, Inc. (OBIO) Free Cash Flow by Year
Orchestra BioMed Holdings, Inc. recorded an outflow of $49.5M in free cash flow in fiscal year 2025. This represents an increase of 2.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $59.1M in free cash flow. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Orchestra BioMed Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OBIO Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
OBIO Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Orchestra BioMed Holdings, Inc. financials
Frequently Asked Questions
What was Orchestra BioMed Holdings, Inc.'s free cash flow in fiscal year 2025?
Orchestra BioMed Holdings, Inc. recorded an outflow of $49.5M in free cash flow in fiscal year 2025.
How fast is Orchestra BioMed Holdings, Inc.'s free cash flow growing?
Orchestra BioMed Holdings, Inc. (OBIO) free cash flow rose by 2.7% year over year, from -$50.8M to -$49.5M in fiscal year 2025.
What is Orchestra BioMed Holdings, Inc.'s free cash flow over the last twelve months?
Orchestra BioMed Holdings, Inc. (OBIO) reported an outflow of $59.1M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Orchestra BioMed Holdings, Inc.'s free cash flow in the most recent quarter?
Orchestra BioMed Holdings, Inc. (OBIO) reported -$19.6M in free cash flow in Q2 2026. This represents a decrease of 25.9% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Orchestra BioMed Holdings, Inc. (OBIO) reported on that line in every period on record.